基本信息

更新日期:
版本:
最新版
大小:
31.93 MB
类型:
医疗
平台:
Windows
评分:
发布日期:
2023-02-21
价格:
免费
开发者:

应用更新

We regularly make changes to TherapySelector. And we import new data on a monthly basis. Please send any feedback or issues via the app. NEW • Data update: added 647 patients from 3 publications. • Guideline update: NIV-NVMDL Nov 2020. IMPROVEMENTS & BUG FIXES • Via the selection page it is now possible to obtain therapy information about Comorbidity ‘HCV-HBV co-infection’. • Fixed issue on the details page with Quality of Evidence.

TherapySelector应用截图

【图】TherapySelector(截图1)【图】TherapySelector(截图2)【图】TherapySelector(截图3)

TherapySelector应用简介

Why use TherapySelector?
TherapySelector is a uniquely handy and complete source of information for the physician and his patient with hepatitis C to select the best fitting treatment.
Guideline recommendations indicate which therapies according to experts are eligible for a particular patient profile.
TherapySelector provides patient profile specific information about the likelihood of cure of hepatitis C infection for all published treatment regimens of FDA and EMA approved drugs, and treatment-specific information about side effects, costs and reimbursement. The cure rates are based on data from phase 2, phase 3 and prospective real-life clinical studies.

TherapySelector is developed by the completely independent TherapySelector organisation (previously LiverDoc), in collaboration with Erasmus Medical Center Rotterdam, the Netherlands Association for the Study of the Liver (NASL), and ExpertDoc.
TherapySelector and ExpertDoc make clinical decision support products to bring unbiased academic knowledge to the busy physician and informed choice to the patient.
Funding of TherapySelector has come from TherapySelector’s own resources without contributions of the pharmaceutical industry.

How is TherapySelector constructed?
TherapySelector connects patient profiles, published treatment combinations and clinical study results.

Patient profiles for chronic HCV infection are based on characteristics crucial for treatment decision making: HCV genotype 1-6, stage of cirrhosis (no/Child A/Child B-C), previous treatment (no/(peg)interferon/sofosbuvir/NS5A+NS3), thereby creating 72 patient profiles. Special comorbidity like HIV co-infection, HBV co-infection, liver transplant, renal failure increases the number of patient profiles further.

Published treatment combinations concern all published treatment combinations based on drugs approved by the FDA and European Medicines Agency.

Study results (cure of infection: HCV RNA not detectable 12-24 weeks after stopping antiviral therapy=SVR) were obtained from published preregistration clinical trials as well as prospective real-life postregistration studies with at least 8 patients with a specific treatment regimen.
From each publication, data (total number of patients treated and SVR evaluable, and number of patients with SVR) were extracted per patient profile. Regularly supplementary data had to be obtained from the first author or study sponsor. After an internal and external check the data were entered into a certified SQL database.

The cure rate (% SVR) was calculated by a computer program, which aggregated the data from various studies for each patient profile – treatment regimen combination, and then divided the number of persons with a cure x 100 by the number of evaluable persons.
Quality of evidence was graded according to a simple system: ‘high’ (at least 80 patients, data from two or more studies), ‘moderate’ (at least 40 patients or 80 patient data from one study) and ‘low’ (less than 40 patients).

Adverse effects are shown if such effects are clinically relevant by its severity or by a higher frequency than in placebo-controlled trials.

Costs and reimbursement information are derived from robust sources like www.hepatitisc.uw.edu (USA), www.base-donnees-publique.medicaments.gouv.fr (FR), www.g-ba.de (DE), www.agenziafarmaco.gov.it (IT), www.vademecum.es (ES), and www.medicijnkosten.nl (NL).

应用特性

• hepatitis
• hepatitis c
• therapy selector
• guideline

类似TherapySelector应用

Aphasia improvement application(Apha..
Aphasia improvement application(Aphasia_English003) for people with English as their mother tongue.I think that this application helps to improve aphasia by using pictures, words, ..
VET-CVI App allows Veterinarians to ..
VET-CVI App allows Veterinarians to create Certificate of Veterinary Inspection VET-CVI App allows Veterinarians to create Certificate of Veterinary Inspection (CVI) for Small And ..
Easy Mode is the only computer softw..
Easy Mode is the only computer software that simultaneously presents opportunities for the visually impaired, while making the computer interface suitable for everyone, regardless ..
Flashcards Anatomy, study aid for do..
Flashcards Anatomy, study aid for doctors, nurses, medical studentsDecks included Terminology, Human, Physiology, Gross, Bones, Skeletal, Heart, Muscular.
Aphasia002.失語症患者(For the Aphasia patients)さんに言葉の練習アプリを(言語聴覚士がつくりました)。10単語の練習ができます(大根,白菜,..
Aphasia002.失語症患者(For the Aphasia patients)さんに言葉の練習アプリを(言語聴覚士がつくりました)。10単語の練習ができます(大根,白菜,南瓜,茄子 葱,薩摩芋,生姜,筍,玉葱,唐辛子)。聴覚的理解、マッチング、呼称などの練習ができます。漢字単語の筆順の確認が出来ます。Aphasia002.Practice words ..
深入研究ERCP手术,以降低患者成本,同时考虑医生的操作经验。我们还开发了配套工具,将影像系统融合进windows操作系统。允许世界各地的医院随时随地获取。 首次运行缺省密码:..
深入研究ERCP手术,以降低患者成本,同时考虑医生的操作经验。我们还开发了配套工具,将影像系统融合进windows操作系统。允许世界各地的医院随时随地获取。 首次运行缺省密码:1 追求卓越和简洁是我们的目标,为之努力! 本应用需要以下驱动或服务: - CP210x 串口驱动,驱动程序需要客户手动安装 - Microsoft Visual C2010 x86 ..
TalkForMePix is a free "Talk For Me"..
TalkForMePix is a free "Talk For Me" Progressive Web App (PWA) running as a Windows 10 App. For people who can not speak or have difficulty speaking clearlySpeak to others by press..
3D Organon is a multi-award winning ..
3D Organon is a multi-award winning self-discovery experience into the human body. You can now visualize the skeletal system, muscles, vessels, nerves, and other organs in 3D. Delv..
May Measurement Month (MMM) is a glo..
May Measurement Month (MMM) is a global synchronised blood pressure screening charity and is endorsed by the International Society of Hypertension (ISH) and the World Hypertension ..
Aplicativo de uso exclusivo dos prof..
Aplicativo de uso exclusivo dos profissionais de saúde. Contém um portfólio completo com os medicamentos da Eurofarma, uma das maiores empresas farmacêuticas do Brasil.
Why use TherapySelector? TherapySele..
Why use TherapySelector? TherapySelector is a uniquely handy and complete source of information for the physician and his patient with hepatitis C to select the best fitting treatm..

TherapySelector应用下载

微软市场应用官网